Invention Grant
- Patent Title: Therapeutic agent for ocular fundus disease
-
Application No.: US15387113Application Date: 2016-12-21
-
Publication No.: US10426783B2Publication Date: 2019-10-01
- Inventor: Tatsuro Ishibashi , Shintaro Nakao , Ryoichi Arita , Ken Mizuno , Akifumi Tsuchiura
- Applicant: KYUSHU UNIVERSITY, NATIONAL UNIVERSITY CORPORATION , KOWA COMPANY, LTD.
- Applicant Address: JP Fukuoka-shi JP Nagoya-shi
- Assignee: KYUSHU UNIVERSITY, NAT'L UNIVERSITY CORPORATION,KOWA COMPANY, LTD.
- Current Assignee: KYUSHU UNIVERSITY, NAT'L UNIVERSITY CORPORATION,KOWA COMPANY, LTD.
- Current Assignee Address: JP Fukuoka-shi JP Nagoya-shi
- Agency: Westerman, Hattori, Daniels & Adrian, LLP
- Priority: JP2013-090851 20130424
- Main IPC: A61K31/551
- IPC: A61K31/551 ; A61K9/00 ; A61K31/496 ; C07D401/12 ; A61K47/10
Abstract:
Disclosed herein is a prophylactic or therapeutic agent for ocular fundus disease, especially diabetic retinopathy or age-related macular degeneration. The prophylactic or therapeutic agent for ocular fundus disease comprising: (S)-(−)-1-(4-fluoro-5-isoquinolinesulfonyl)-2-methyl-1,4-homopiperazine, a salt thereof, or a solvate thereof, as an active ingredient.
Public/Granted literature
- US20170100409A1 THERAPEUTIC AGENT FOR OCULAR FUNDUS DISEASE Public/Granted day:2017-04-13
Information query
